1. Scott DA, Baqar S, Pazzaglia G, Guerry P, Burr DH. Vaccines against Campylobacter jejuni. In: Levine MM, Woodrow GC, Kaper JB, Cobon GS, editors. New generation vaccines, 2nd ed. [revised and expanded]. New York: Marcel Dekker, Inc.; 1997. p. 885–896.
2. Friedman CR, Neimann J, Wegener C, Tauxe RV. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. In: Nachamkin I, Blaser MJ, editors. Campylobacter, 2nd ed. Washington, DC: American Society for Microbiology; 2000. p. 121–138.
3. Oberhelman RA, Taylor DN. Campylobacter infections in developing countries. In: Nachamkin I, Blaser MJ, editors. Campylobacter, 2nd ed. Washington, DC: American Society for Microbiology; 2000. p. 139–153.
4. Campylobacter species and Guillain-Barré syndrome;Nachamkin;Clin. Microbiol. Rev.,1998
5. Newell DG, Nachamkin I. Immune responses directed against Campylobacter jejuni. In: Nachamkin I, Blaser MJ, Tompkins LS, editors. Campylobacter jejuni, Current Status and Future Trends. Washington, DC: American Society for Microbiology; 1992. p. 201–206.